Chickenpox Vaccine for Risk Groups

Supply of chickenpox vaccine for risk groups: possibility of reducing the purchase of the medicinal product by up to 20% per part. A valid marketing authorization for the medicinal product is required, issued by the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, or by the Council of the European Union or the European Commission, valid on the date of offer submission and for the entire contract period. Foreign language documents must be submitted with a Polish translation; further items as per the tender documents.

Tender documents

Lots (3)

• LOT-0001Windpockenimpfstoff für Risikogruppen, Los 1
• LOT-0002Windpockenimpfstoff für Risikogruppen, Los 2
• LOT-0003Windpockenimpfstoff für Risikogruppen, Los 3

Additional details